ALYFTREK
NDC 51167-121, vanzacaftor, tezacaftor, and deutivacaftor, tablet, film coated, from Vertex Pharmaceuticals Incorporated.
- Product NDC
- 51167-121
- Status
- Listed
- Labeler
- Vertex Pharmaceuticals Incorporated
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA218730
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51167-121 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- VANZACAFTOR10 mg/1
- TEZACAFTOR50 mg/1
- DEUTIVACAFTOR125 mg/1
Pharmacologic classes
Breast Cancer Resistance Protein Inhibitors [MoA]; Chloride Channel Activation Potentiators [MoA]; Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]; Cytochrome P450 2C9 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51167-121-01 | 51167012101 | 4 BLISTER PACK in 1 CARTON (51167-121-01) / 14 TABLET, FILM COATED in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7e635909-c6fd-4f0d-ae77-cdff03653a20
Use it
Look up 51167-121 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51167-121 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51167-121. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.